acetazolamide has been researched along with Bipolar Disorder in 4 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Bipolar Disorder: A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acetazolamide is a carbonic anhydrase inhibitor used for a variety of purposes, including adjunctively in the management of various types of epilepsy." | 2.67 | Acetazolamide in bipolar affective disorders. ( Hayes, SG, 1994) |
| "Acetazolamide was added to a low dose of valproic acid and to perazine." | 1.30 | Acetazolamide in the treatment of acute mania. A case report. ( Brandt, C; Grunze, H; Normann, C; Walden, J, 1998) |
| "Acetazolamide was given to 30 patients: Type I, puberal periodic psychosis, a psychosis whose onset occurs during the period of puberty and which appears repetitively with psychosis-like condition at about the same interval as the menstrual cycle (6 cases); Type II, a) presenile atypical psychosis which initially appears in patients in their 20s or 30s accompanied by manic-depressive cycles and shows acute confusional and dreamy states in the presenile period, incurable cases (7), b) atypical psychosis, in the narrow sense, cases which show acute hallucination, delusion, confusional and dreamy states accompanied by affective symptoms (8 cases); Type III, repetitively the atypical manic and depressive states, and atypical manic-depressive psychosis, and transient changes in consciousness, refractory cases (2); Type IV, atypical schizophrenia, which is considered to be schizophrenia but shows the abnormalities in electroencephalogram and emotional disorders (7 cases)." | 1.27 | Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis. ( Fukuma, E; Hamazoe, K; Hazama, H; Ichikawa, M; Inoue, H; Inoue, K; Omura, F; Umezawa, Y, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schaffer, A | 1 |
| Cairney, J | 1 |
| Cheung, A | 1 |
| Veldhuizen, S | 1 |
| Kurdyak, P | 1 |
| Levitt, A | 1 |
| Inoue, H | 1 |
| Hazama, H | 1 |
| Hamazoe, K | 1 |
| Ichikawa, M | 1 |
| Omura, F | 1 |
| Fukuma, E | 1 |
| Inoue, K | 1 |
| Umezawa, Y | 1 |
| Hayes, SG | 1 |
| Brandt, C | 1 |
| Grunze, H | 1 |
| Normann, C | 1 |
| Walden, J | 1 |
1 trial available for acetazolamide and Bipolar Disorder
| Article | Year |
|---|---|
Acetazolamide in bipolar affective disorders.
Topics: Acetazolamide; Adult; Aged; Bipolar Disorder; Cross-Over Studies; Dose-Response Relationship, Drug; | 1994 |
3 other studies available for acetazolamide and Bipolar Disorder
| Article | Year |
|---|---|
Differences in prevalence and treatment of bipolar disorder among immigrants: results from an epidemiologic survey.
Topics: Acetazolamide; Adult; Bipolar Disorder; Canada; Emigrants and Immigrants; Female; Health Services Ac | 2009 |
Antipsychotic and prophylactic effects of acetazolamide (Diamox) on atypical psychosis.
Topics: Acetazolamide; Adolescent; Adult; Bipolar Disorder; Carbamazepine; Electroencephalography; Female; H | 1984 |
Acetazolamide in the treatment of acute mania. A case report.
Topics: Acetazolamide; Adult; Antimanic Agents; Bipolar Disorder; Carbonic Anhydrase Inhibitors; Humans; Mal | 1998 |